Powerful Medical
9. April 2024

Forbes 30 Under 30 Europe: Powerful Medical Founders Join 2024 Class

In a world where medical technology advances at an unprecedented pace, it’s the visionaries and innovators who lead the way in transforming healthcare. This year, we are honored to share that our co-founders, Martin Herman and Robert Herman, MD, have been recognized as part of the prestigious Forbes 30 Under 30 Europe 2024 list for their exceptional work in reshaping cardiovascular care.

Forbes 30 Under 30 Europe: A Closer Look

The Forbes 30 Under 30 list was launched in 2011 as a platform to recognize and celebrate the most promising young entrepreneurs, innovators, and game-changers across various industries. The list quickly gained prestige, becoming a sought-after accolade for individuals under the age of 30 who are making significant impacts in fields like technology, healthcare, finance, and the arts.

In 2016, Forbes expanded this initiative to create the Forbes 30 Under 30 Europe list, which spotlights young leaders from across the European continent. This list similarly honors 300 individuals annually, who are selected through a rigorous process involving nominations and evaluations by industry experts. Both lists have since become symbols of excellence and a testament to the power of youthful innovation and leadership.

The selection process is highly competitive, involving thorough evaluation by industry experts who assess candidates based on their creativity, impact, and potential to shape the future.

Being named to the Forbes 30 Under 30 Europe list not only recognizes these individuals’ remarkable achievements but also connects them to a global network of forward-thinking professionals and influencers. The nomination exemplifies the spirit of European innovation, blending cutting-edge technology with a commitment to societal betterment.

Powerful Medical Founders Honored in Forbes 30 Under 30 Europe

Selected from thousands of nominations, Martin and Robert’s inclusion in this list reflects their dedication to revolutionizing cardiac diagnostics through artificial intelligence. Addressing the largest untapped market in healthcare, Powerful Medical is committed to the early detection and timely management of acute heart attacks and 38 other heart conditions. With cardiovascular diseases being the leading cause of death worldwide, our mission has the potential to significantly improve and save the lives of countless cardiac patients.

Combining cutting-edge AI with deep medical expertise, we now provide more than 35,000 healthcare professionals in 16 markets with innovative diagnostic technology, with over 30 centers of excellence in the validation process. Our certified AI-powered ECG interpretation platform, PMcardio, enables quicker and more accurate detection of heart attacks, facilitating timely intervention that can significantly improve patient outcomes.

To compile the Forbes Europe 30 Under 30 ninth annual list, Forbes’ team delved into thousands of submissions online and sought recommendations from industry insiders and previous listees. The Forbes team, alongside an independent panel of judges, including notable figures like Renzo Rosso, Simona Tabasco, and Mo Farah, evaluated candidates based on factors such as funding, revenue, social impact, scale, creativity, and future potential.

We could not have reached this milestone without the hard work and dedication of our entire team. Every day, their expertise and passion help bring our vision closer to reality. Our journey is also supported by our investors and partners, whose faith in our mission has been invaluable.

Celebrating this achievement, we also extend our congratulations to everyone recognized in this year’s Forbes 30 Under 30 list. These individuals serve as an inspiration to us and, undoubtedly, to the generations that will follow.

As we continue our journey to enter new markets, integrate PMcardio into more healthcare institutions, accumulate more clinical evidence, and develop new AI models for conditions like heart failure, the recognition by Forbes inspires us to further innovate cardiovascular care, aiming to make a meaningful impact on patient lives worldwide.

For a closer look at the Forbes 30 Under 30 Europe 2024 list and to discover more about the innovative leaders shaping our world, visit the Forbes website.

As we move forward, we remain committed to our mission of transforming cardiovascular care with AI. Together, we are setting new standards in healthcare, one diagnosis at a time. The journey ahead is promising, and we are just getting started.

Forbes 30 Under 30 Europe: Powerful Medical Founders Join 2024 Class
Forbes 30 Under 30 Europe: Powerful Medical Founders Join 2024 Class

Stay on the pulse with our newsletter

Your submission was successful

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Left Ventricular Systolic Dysfunction (LVSD) (2)

Left Ventricular Systolic Dysfunction: The Basics and AI Advancements in Detection

In this comprehensive article, we delve into the intricacies of Left Ventricular Systolic Dysfunction (LVSD), thoroughly analyzing its symptoms, causes, and severity. We explore the latest advancements in diagnostic tools and real-world case studies.

Dr. Schmelzer’s Turning Point: How a Severe Chest Pain Case Inspired PMcardio Adoption

The case of a 76-year-old patient with severe chest pain prompted Dr. Schmelzer to delve into the nuances of Occlusive Myocardial Infarction (OMI) versus the conventional STEMI/NSTEMI classification. His research led him to discover the PMcardio OMI AI model.

Join 25,000 healthcare professionals who are already taking advantage of AI